ProfileGDS4718 / 1554757_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 34% 29% 32% 31% 26% 25% 19% 35% 23% 31% 44% 22% 32% 26% 21% 25% 33% 26% 21% 14% 44% 32% 33% 29% 31% 22% 28% 21% 28% 19% 20% 26% 25% 39% 19% 28% 20% 24% 31% 46% 33% 21% 15% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.7281834
GSM549102patient 115, normal, homogenized [OPG study]4.5154829
GSM549104patient 119, normal, homogenized [OPG study]4.6217832
GSM549108patient 138, normal, homogenized [OPG study]4.6313531
GSM549119patient 077, normal, homogenized [OPG study]4.3750126
GSM549133patient 032, cancer, homogenized [OPG study]4.2658525
GSM549139patient 042, cancer, homogenized [OPG study]4.1014819
GSM549099patient 107, normal, homogenized [OPG study]4.7588135
GSM549109patient 139, normal, homogenized [OPG study]4.2960223
GSM549110patient 046, normal, homogenized [OPG study]4.592731
GSM549114patient 063, normal, homogenized [OPG study]5.1548644
GSM549122patient 082, normal, homogenized [OPG study]4.2389522
GSM549134patient 033, cancer, homogenized [OPG study]4.6286532
GSM549136patient 036, cancer, homogenized [OPG study]4.3294126
GSM549140patient 044, cancer, homogenized [OPG study]4.133121
GSM549111patient 047, normal, homogenized [OPG study]4.320925
GSM549113patient 057, normal, homogenized [OPG study]4.624433
GSM549132patient 031, cancer, homogenized [OPG study]4.3658826
GSM549137patient 038, cancer, homogenized [OPG study]4.1638321
GSM549142patient 047, cancer, homogenized [OPG study]3.976714
GSM549100patient 110, normal, homogenized [OPG study]5.238544
GSM549107patient 135, normal, homogenized [OPG study]4.5763632
GSM549115patient 068, normal, homogenized [OPG study]4.5909433
GSM549116patient 072, normal, homogenized [OPG study]4.4650329
GSM549120patient 078, normal, homogenized [OPG study]4.5658131
GSM549131patient 030, cancer, homogenized [OPG study]4.1901922
GSM549118patient 074, normal, homogenized [OPG study]4.4468428
GSM549129patient 027, cancer, homogenized [OPG study]4.1856321
GSM549123patient 088, normal, homogenized [OPG study]4.4369528
GSM549124patient 006, cancer, homogenized [OPG study]4.158319
GSM549126patient 015, cancer, homogenized [OPG study]4.1207920
GSM549128patient 025, cancer, homogenized [OPG study]4.3492926
GSM549103patient 117, normal, homogenized [OPG study]4.3961225
GSM549117patient 073, normal, homogenized [OPG study]4.8915839
GSM549138patient 041, cancer, homogenized [OPG study]4.080419
GSM549141patient 045, cancer, homogenized [OPG study]4.3933428
GSM549130patient 028, cancer, homogenized [OPG study]4.1636220
GSM549101patient 111, normal, homogenized [OPG study]4.3337424
GSM549105patient 128, normal, homogenized [OPG study]4.6025931
GSM549106patient 134, normal, homogenized [OPG study]5.2299646
GSM549112patient 048, normal, homogenized [OPG study]4.6497833
GSM549125patient 011, cancer, homogenized [OPG study]4.2054921
GSM549127patient 024, cancer, homogenized [OPG study]3.9449115
GSM549135patient 035, cancer, homogenized [OPG study]4.325926